Performance analysis of Atyr Pharma (ATYR)
Annual Return
Over the past 3 years, ATYR has had an average annual return of -38.61%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, ATYR has had an average annual return of -35.96%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, ATYR has had an average annual return of -35.84%, underperforming the benchmark SPY, which returned +14.95% annual.
Since May 7, 2015, ATYR has had an average annual return of -41.83%, underperforming the benchmark SPY, which returned +13.86% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -37.84% | -78.61% | +158.21% | -36.19% | -70.59% | +92.97% | -7.04% | -40.06% | -85.82% | +62.80% | -78.13% | -34.25% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +13.51% | +9.52% | -19.57% | +5.41% | -33.33% | +11.54% | -20.69% | -37.84% | |||||
| 2025 | +6.36% | +2.72% | -23.81% | +15.28% | +28.92% | +13.08% | -6.61% | +13.72% | -86.77% | +20.59% | -9.76% | +0% | -78.61% |
| 2024 | +13.43% | +21.05% | +1.09% | -19.35% | +10.67% | -9.64% | +26.67% | -6.32% | -5.62% | +77.38% | +13.42% | +2.37% | +158.21% |
| 2023 | +4.76% | -8.18% | -0.99% | -7.00% | +16.13% | -4.63% | -8.74% | -13.83% | -7.41% | -20.00% | +3.33% | +8.06% | -36.19% |
| 2022 | -23.81% | -12.87% | +8.02% | -22.27% | -32.66% | +0.75% | +24.44% | -2.98% | -12.27% | -17.48% | -12.71% | +1.94% | -70.59% |
| 2021 | -5.41% | +18.86% | +2.40% | -8.92% | +11.86% | +7.37% | -4.29% | +17.94% | +65.02% | -5.53% | -2.93% | -10.30% | +92.97% |
| 2020 | +21.61% | -26.86% | -24.29% | +28.36% | +4.07% | +18.44% | -10.85% | -4.76% | -14.44% | -1.95% | +37.75% | -11.06% | -7.04% |
| 2019 | +0.90% | -4.18% | +14.64% | +12.77% | -30.36% | -15.22% | -31.43% | -16.67% | +19.29% | +2.99% | +34.30% | -13.85% | -40.06% |
| 2018 | +1.45% | -16.93% | -10.14% | -15.12% | -59.87% | +0.83% | -14.78% | -6.94% | +12.42% | -25.05% | +1.23% | -19.42% | -85.82% |
| 2017 | +53.48% | +21.25% | -12.52% | -5.72% | +0% | +3.04% | +1.50% | -11.61% | +65.59% | -4.94% | -18.75% | -10.27% | +62.80% |
Drawdown analysis of Atyr Pharma (ATYR)
The maximum drawdown for the ATYR was -99.90%, occurring on May 13, 2026. This drawdown has not yet recovered.
The current ATYR drawdown is -99.88%.
Since May 7, 2015 ATYR has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.90% | Jun 3, 2015 | 2752 | May 13, 2026 | Ongoing | Ongoing | Ongoing |
| -9.67% | May 26, 2015 | 3 | May 29, 2015 | 3 | Jun 3, 2015 | 6 |
| -9.18% | May 12, 2015 | 1 | May 13, 2015 | 5 | May 20, 2015 | 6 |